Hengchuang Yin

Prof. Hengchuang Yin

bioinformatics, Chinese Academy of Sciences, Beijing, China
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2025 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
DLDongxu Li
Dongxu Li
YYYue Yang
Yue Yang
ZCZiwen Cui
Ziwen Cui
Hengchuang YinHengchuang Yin
Hengchuang Yin
PHPeng-Wei Hu
Peng-Wei Hu
LHLun Hu
Lun Hu
Drug-drug interaction (DDI) refers to the interaction relationships between drugs. Discovering new DDIs is crucial for advancing drug development and enhancing clinical treatments. Given the significant progress achieved through graph neural networks (GNNs), network-based models have become a prevalent approach for tackling this challenge. However, current network-based approaches are incapable of seamlessly integrating a wide range of information. Motivated by this discovery, we propose a novel model, namely LLM-DDI, which aims to comprehensively tackle DDI prediction tasks by integrating various information of molecules in the BKG. LLM-DDI initially incorporates the generative pre-trained transformer (GPT) model to generate embeddings for each molecule within the biomedical knowledge graph (BKG). These embeddings encompass diverse types of information pertaining to each molecule. Subsequently, LLM-DDI utilizes a message-passing GNN framework to enhance the learning of molecular representations with the embeddings derived from GPT as input. LLM-DDI governs the propagation of information within the BKG by semantic relationships. These semantic relationships determine how information flows and is exchanged between different entities in the BKG. Finally, LLM-DDI leverages the learned drug representations to predict potential DDIs. Experiments show the effectiveness of LLM-DDI, as it achieves the best performance on two real-world datasets, providing valuable guidance for drug development and clinical treatment.

2 January 2024 in GigaScience
Verified
Journal Article
Open access
PDF file
Hengchuang YinHengchuang Yin
Hengchuang Yin
SWShufang Wu
Shufang Wu
JTJie Tan
Jie Tan
QGQian Guo
Qian Guo
MLMo Li
Mo Li
HZHuaiqiu Zhu
Huaiqiu Zhu
Background: The virome obtained through virus-like particle enrichment contains a mixture of prokaryotic and eukaryotic virus-derived fragments. Accurate identification and classification of these elements are crucial to understanding their roles and functions in microbial communities. However, the rapid mutation rates of viral genomes pose challenges in developing high-performance tools for classification, potentially limiting downstream analyses. Findings: We present IPEV, a novel method to distinguish prokaryotic and eukaryotic viruses in viromes, with a 2-dimensional convolutional neural network combining trinucleotide pair relative distance and frequency. Cross-validation assessments of IPEV demonstrate its state-of-the-art precision, significantly improving the F1-score by approximately 22% on an independent test set compared to existing methods when query viruses share less than 30% sequence similarity with known viruses. Furthermore, IPEV outperforms other methods in accuracy on marine and gut virome samples based on annotations by sequence alignments. IPEV reduces runtime by at most 1,225 times compared to existing methods under the same computing configuration. We also utilized IPEV to analyze longitudinal samples and found that the gut virome exhibits a higher degree of temporal stability than previously observed in persistent personal viromes, providing novel insights into the resilience of the gut virome in individuals. Conclusions: IPEV is a high-performance, user-friendly tool that assists biologists in identifying and classifying prokaryotic and eukaryotic viruses within viromes. The tool is available at https://github.com/basehc/IPEV.

28 April 2026 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
XZXiaobo Zhu
Xiaobo Zhu
XDXun Deng
Xun Deng
ZZZimai Zhang
Zimai Zhang
YQYujie Qi
Yujie Qi
Hengchuang YinHengchuang Yin
Hengchuang Yin
PHPengwei Hu
Pengwei Hu
Drug repositioning accelerates therapeutic development by revealing novel indications for approved compounds, yet existing methods typically rely on single information sources and fail to integrate multi-scale biological mechanisms spanning molecular similarity, target selectivity, and multi-step regulatory pathways. Here we introduce FD-MSGL, a Frequency-Domain Multi-Source Synergistic Graph Learning framework that addresses this challenge by integrating three complementary biological information sources. FD-MSGL constructs homogeneous semantic graphs to capture molecular similarity in chemical space, heterogeneous graphs to model direct drug-protein-disease interactions revealing target selectivity, and pathway regulation graphs to trace indirect therapeutic mechanisms through multi-step regulatory cascades. Through frequency-domain decomposition, FD-MSGL simultaneously models local specificity of molecular recognition and global organizational patterns of drug families. The framework quantifies biological synergies across molecular, target, and pathway levels, integrates complementary evidence from chemical similarity, target selectivity, and regulatory mechanisms, and dynamically balances precise structural matching with global therapeutic pattern consistency. Empirical evaluation across three benchmark datasets demonstrates that FD-MSGL achieves competitive performance.

30 May 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
Hengchuang YinHengchuang Yin
Hengchuang Yin
SWShufang Wu
Shufang Wu
JTJie Tan
Jie Tan
QGQian Guo
Qian Guo
MLMo Li
Mo Li
HZHuaiqiu Zhu
Huaiqiu Zhu
Background The virome obtained through virus-like particle enrichment contain a mixture of prokaryotic and eukaryotic virus-derived fragments. Accurate identification and classification of these elements are crucial for understanding their roles and functions in microbial communities. However, the rapid mutation rates of viral genomes pose challenges in developing high-performance tools for classification, potentially limiting downstream analyses. Findings We present IPEV, a novel method that combines trinucleotide pair relative distance and frequency with a 2D convolutional neural network for distinguishing prokaryotic and eukaryotic viruses in viromes. Cross-validation assessments of IPEV demonstrate its state-of-the-art precision, significantly improving the F1-score by approximately 22% on an independent test set compared to existing methods when query viruses share less than 30% sequence similarity with known viruses. Furthermore, IPEV outperforms other methods in terms of accuracy on most real virome samples when using sequence alignments as annotations. Notably, IPEV reduces runtime by 50 times compared to existing methods under the same computing configuration. We utilized IPEV to reanalyze longitudinal samples and found that the gut virome exhibits a higher degree of temporal stability than previously observed in persistent personal viromes, providing novel insights into the resilience of the gut virome in individuals. Conclusions IPEV is a high-performance, user-friendly tool that assists biologists in identifying and classifying prokaryotic and eukaryotic viruses within viromes. The tool is available at https://github.com/basehc/IPEV.


1 January 2026 in IEEE Transactions on Multimedia
Verified
Journal Article
Closed access
YYYue Yang
Yue Yang
DLDongxu Li
Dongxu Li
ZCZiwen Cui
Ziwen Cui
Hengchuang YinHengchuang Yin
Hengchuang Yin
LHLun Hu
Lun Hu